Holen Sie sich die Stockscreener-App
22.46
2.00%
0.44
Vorhandelsmarkt:
22.42
-0.04
-0.18%
Schlusskurs vom Vortag:
$22.02
Offen:
$22.6
24-Stunden-Volumen:
20.23M
Relative Volume:
0.66
Marktkapitalisierung:
$5.12B
Einnahmen:
$2.35B
Nettoeinkommen (Verlust:
$128.37M
KGV:
43.02
EPS:
0.5221
Netto-Cashflow:
$57.42M
1W Leistung:
-9.73%
1M Leistung:
+44.81%
6M Leistung:
-59.89%
1J Leistung:
-35.37%
1-Tages-Spanne:
$22.25
$23.10
1-Wochen-Bereich:
$21.70
$25.24
52-Wochen-Spanne:
$13.74
$70.43
Hims Hers Health Inc Stock (HIMS) Company Profile
Firmenname
Hims Hers Health Inc
Sektor
Telefon
415-851-0195
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
22.46 | 5.12B | 2.35B | 128.37M | 57.42M | 0.5221 |
TAK
Takeda Pharmaceutical Co Adr
|
17.86 | 56.42B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.23 | 48.64B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.93 | 44.33B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.77 | 33.51B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
521.22 | 22.84B | 3.18B | 1.33B | 1.04B | 27.90 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2026-03-10 | Hochstufung | Citigroup | Sell → Neutral |
| 2026-03-09 | Hochstufung | Needham | Hold → Buy |
| 2026-02-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2026-01-12 | Eingeleitet | Evercore ISI | In-line |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-10-21 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | Herabstufung | Needham | Buy → Hold |
| 2025-06-04 | Bestätigt | Needham | Buy |
| 2025-04-29 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-01-07 | Eingeleitet | BTIG Research | Buy |
| 2024-12-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-08-22 | Eingeleitet | Needham | Buy |
| 2024-08-09 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-04-16 | Herabstufung | Jefferies | Buy → Hold |
| 2024-04-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-02-28 | Hochstufung | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | Imperial Capital | In-line |
| 2023-07-28 | Eingeleitet | TD Cowen | Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-02-09 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-07-15 | Eingeleitet | SVB Leerink | Underperform |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-10 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-11-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Eingeleitet | BofA Securities | Neutral |
| 2021-05-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Eingeleitet | Truist | Hold |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-03-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Eingeleitet | Citigroup | Neutral |
| 2021-02-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-02-08 | Eingeleitet | Tigress Financial | Buy |
Alle ansehen
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH Stock? - TradingView
Hims & Hers Expands Integrated Digital Healthcare Ecosystem - Yahoo! Finance Canada
What triggered Hims & Hers Health shares' latest price surge - Traders Union
+3.72% for Hims & Hers Health stock as buyers dominate intraday despite mixed momentum - Traders Union
Hims & Hers Stock Fell 11.5% After Novo Deal Bounce. Here’s What the Market Is Pricing In - TIKR.com
India's Generic Wave Hits Ozempic And Wegovy As Prices Drop Sharply - Benzinga
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo! Finance Canada
2 Healthcare Stocks to Target This Week and 1 That Underwhelm - The Globe and Mail
Canaccord Lowers Hims & Hers Health, Inc. (HIMS) Price Target Patent Amid Dispute and FDA Scrutiny - MSN
Hims & Hers (HIMS) soars 10.3% on analyst upgrades, new deal - MSN
Hims & Hers (HIMS) tumbles 8.86% on market bloodbath, profit-taking - MSN
Hims & Hers (HIMS) Tumbles 8.86% on Market Bloodbath, Profit-Taking - Insider Monkey
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc.HIMS - Morningstar
Does Hims & Hers (HIMS) Novo Nordisk Deal Quietly Redraw Its Risk Reward Profile? - Yahoo Finance
Hims Says Failed Wegovy Collab Doesn't Merit Investor Suit - Law360
Hims & Hers stock falls as technical resistance weighs and buyers lose steam near $24 - Traders Union
Hims & Hers Elevates Technology-Driven Healthcare Accessibility - MSN
Investor relations - HIMS Investor Relations
Hims & Hers Opens Waitlist For $149 Branded Wegovy And Ozempic Via Novo Nordisk Deal - Sahm
Hims & Hers Health stock: Daily momentum and support levels drive a 3.41% advance - Traders Union
Buying pressure lifts Hims & Hers Health stock higher in today's trading - Traders Union
Understanding Momentum Shifts in (HIMS) - Stock Traders Daily
Barclays raises PT on Hims & Hers Health (HIMS) stock - MSN
Hims & Hers Health, Inc. (HIMS) suffers a larger drop than the general market: Key insights - MSN
Insider Sell: Irene Becklund Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus
Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Hims & Hers Health Faces Another Legal Setback Amid Probes and Falling Shares - StocksToTrade
Insider Selling: Hims & Hers Health (NYSE:HIMS) COO Sells 97,289 Shares of Stock - MarketBeat
Hims & Hers Health (NYSE:HIMS) Insider Sells $136,511.01 in Stock - MarketBeat
Hims & Hers health COO Chi sells $2.4m in shares - Investing.com
Top Healthcare Stocks To Follow TodayMarch 18th - MarketBeat
Hims & Hers Opens Up Pre-Launch Waitlist For Ozempic And Wegovy Following Partnership With Novo Nordisk - Stocktwits
Telemedicine company Hims & Hers Health Inc. (NYSE: HIMS) announced that its service platform will expand its product range to include Novo Nordisk's Wegovy® (semaglutide) oral tablets and injections, as well as Ozempic® injections. - Bitget
A New Era of Weight Management is Coming to Hims & Hers - Hims & Hers Newsroom
Greenfield Seitz Capital Management LLC Sells 43,334 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move - Yahoo Finance
Hims & Hers Health Options Spot-On: On March 17th, 130.34K Contracts Were Traded, With 1.27 Million Open Interest - Moomoo
COO Michael Chi settles RSUs, tax withholding at Hims & Hers (NYSE: HIMS) - Stock Titan
Hims & Hers (NYSE: HIMS) director converts 15,211 RSUs to shares - Stock Titan
Hims & Hers (NYSE: HIMS) CMO reports RSU vesting and tax share withholding - Stock Titan
Hims & Hers (HIMS) executive settles 32,919 RSUs, shares withheld for tax - Stock Titan
Hims & Hers (HIMS) CEO logs RSU vesting and large tax share withholding - Stock Titan
[Form 4] Hims & Hers Health, Inc. Insider Trading Activity - Stock Titan
Healthcare Stocks To ConsiderMarch 17th - MarketBeat
HIMS Stock: After a 57% Surge, Is It Time to Buy Hims & Hers? - CMC Markets
Hims & Hers Health shares see a dip — What is pressuring the stock - Traders Union
Hims & Hers Health, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Aquatic Capital Management LLC Purchases New Stake in Hims & Hers Health, Inc. $HIMS - MarketBeat
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market - MSN
HIMS: Leerink Partners Raises Price Target to $25.00 | HIMS Stoc - GuruFocus
Hims & Hers Health (NYSE:HIMS) Price Target Raised to $25.00 at Leerink Partners - MarketBeat
Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
1.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):